Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease

Title
Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
Authors
Keywords
-
Journal
CLINICAL NEUROPHARMACOLOGY
Volume 36, Issue 1, Pages 14-23
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-01-17
DOI
10.1097/wnf.0b013e31827db49b

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started